The Beauty Health Company reported Q1 2025 revenue of $69.6M (-14.5% YoY), beat analyst consensus of $63.1M by $6.5M. Diluted EPS came in at $-0.08 (+20.0% YoY), beat the $-0.13 consensus by $0.05.
Trailing eight quarters through Q1 2025
Common questions about The Beauty Health Company's Q1 2025 earnings report.
The Beauty Health Company (SKIN) reported Q1 2025 earnings on May 8, 2025 after market close.
The Beauty Health Company reported revenue of $69.6M and diluted EPS of $-0.08 for Q1 2025.
Revenue beat the consensus estimate of $63.1M by $6.5M. EPS beat the consensus estimate of $-0.13 by $0.05.
Compared to the same quarter a year prior, revenue declined 14.5% from $81.4M a year earlier and diluted EPS grew 20.0% from $-0.10.
You can read the 10-Q periodic report (0001628280-25-023922) directly on SEC EDGAR. The filing index links above go to sec.gov.